ArticleLung Cancer (Auckland, N.Z.)2023

ALESIA 5-Year Update: Alectinib at 600 mg Twice Daily Gives Lorlatinib a Run for Its Money in Asia.

Alexandria T M Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.